<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01859130</url>
  </required_header>
  <id_info>
    <org_study_id>CSU2012-10K</org_study_id>
    <nct_id>NCT01859130</nct_id>
  </id_info>
  <brief_title>Zimmer POLAR - Total Knee Arthroplasty (TKA)</brief_title>
  <official_title>Persona Outcomes Led Assessment Research in Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to obtain implant survivorship and clinical outcomes&#xD;
      data for commercially available Persona fixed bearing knee implants used in total knee&#xD;
      arthroplasty. The assessment will include implant survivorship and clinical performance&#xD;
      measured by pain and function, quality of life data, radiographic parameters and&#xD;
      survivorship.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study design is a prospective, multicenter, study of the commercially available Persona&#xD;
      fixed bearing knee implants. The study will require each site to obtain Institutional Review&#xD;
      Board (IRB) approval prior to study enrollment. All potential study subjects will be required&#xD;
      to participate in the Informed Consent Process.&#xD;
&#xD;
      All study subjects will undergo preoperative clinical evaluations prior to their total knee&#xD;
      arthroplasty. The post-operative clinical and radiographic evaluations will be conducted at 6&#xD;
      weeks, 6 months, 1 year, 2, 3, 4, and 5 years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 21, 2013</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Knee Society Scores</measure>
    <time_frame>5 years post op</time_frame>
    <description>Knee Society Scores</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EQ-5D</measure>
    <time_frame>5 years post op</time_frame>
    <description>EQ-5D</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>RheumatoId Arthritis</condition>
  <condition>Traumatic Arthritis</condition>
  <condition>Polyarthritis</condition>
  <arm_group>
    <arm_group_label>Persona TKA</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Primary total knee arthroplasty subjects that receive the Zimmer Persona Total Knee System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Zimmer Persona Total Knee System</intervention_name>
    <arm_group_label>Persona TKA</arm_group_label>
    <other_name>Primary Knee Replacement,</other_name>
    <other_name>Total Knee Arthroplasty,</other_name>
    <other_name>Total Knee Replacement</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient 18-75 years of age, inclusive;&#xD;
&#xD;
          -  Patient qualifies for primary total knee arthroplasty based on physical exam and&#xD;
             medical history, including diagnosis of severe knee pain and disability due to at&#xD;
             least one of the following:&#xD;
&#xD;
               -  rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis;&#xD;
&#xD;
               -  collagen disorders and/or avascular necrosis of the femoral condyle;&#xD;
&#xD;
               -  post-traumatic loss of joint configuration, particularly when there is&#xD;
                  patellofemoral erosion, dysfunction or prior patellectomy;&#xD;
&#xD;
               -  moderate valgus, varus, or flexion deformities;&#xD;
&#xD;
               -  the salvage of previously failed surgical attempts that did not include partial&#xD;
                  or total knee arthroplasty of the ipsilateral knee;&#xD;
&#xD;
          -  Patient has participated in a study-related Informed Consent process;&#xD;
&#xD;
          -  Patient is willing and able to complete scheduled study procedures and follow-up&#xD;
             evaluations;&#xD;
&#xD;
          -  Independent of study participation, patient is a candidate for commercially available&#xD;
             Persona fixed bearing knee components implanted in accordance with product labeling.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient is currently participating in any other surgical intervention studies or pain&#xD;
             management studies;&#xD;
&#xD;
          -  Previous history of infection in the affected joint and/or other local/systemic&#xD;
             infection that may affect the prosthetic joint;&#xD;
&#xD;
          -  Insufficient bone stock on femoral or tibial surfaces;&#xD;
&#xD;
          -  Skeletal immaturity;&#xD;
&#xD;
          -  Neuropathic arthropathy;&#xD;
&#xD;
          -  Osteoporosis or any loss of musculature or neuromuscular disease that compromises the&#xD;
             affected limb;&#xD;
&#xD;
          -  Stable, painless arthrodesis in a satisfactory functional position;&#xD;
&#xD;
          -  Severe instability secondary to the absence of collateral ligament integrity;&#xD;
&#xD;
          -  Rheumatoid arthritis accompanied by an ulcer of the skin or a history of recurrent&#xD;
             breakdown of the skin;&#xD;
&#xD;
          -  Patient has a known or suspected sensitivity or allergy to one or more of the implant&#xD;
             materials;&#xD;
&#xD;
          -  Patient is pregnant or considered a member of a protected population (e.g., prisoner,&#xD;
             mentally incompetent, etc.);&#xD;
&#xD;
          -  Patient has previously received partial or total knee arthroplasty for the ipsilateral&#xD;
             knee.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kacy Arnold, RN MBA</last_name>
    <role>Study Director</role>
    <affiliation>Zimmer Biomet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Midwest Orthopaedics at Rush</name>
      <address>
        <city>Naperville</city>
        <state>Illinois</state>
        <zip>60563</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Rothman Institute</name>
      <address>
        <city>Egg Harbor Township</city>
        <state>New Jersey</state>
        <zip>08234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Rothman Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 16, 2013</study_first_submitted>
  <study_first_submitted_qc>May 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2013</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

